Belzutifan
id:
belzutifan-210-3431811
title:
Belzutifan
text:
Belzutifan, sold under the brand name Welireg, is an anti-cancer medication used for the treatment of von Hippel–Lindau disease-associated renal cell carcinoma. It is taken by mouth. Belzutifan is an hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor. Belzutifan's capacity to reduce serum erythropoietin verified its clinical applicability for the treatment of malignancies linked to von Hippel-Lindau (VHL), such as renal cell carcinoma (RCC) with clear cell histology (ccRCC), pancreatic lesions,
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Belzutifan
date created:
2021-04-26T05:21:26Z
date modified:
2024-09-12T00:56:05Z
main entity:
{"identifier":"Q27456641","url":"https://www.wikidata.org/entity/Q27456641"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/4/4c/Belzutifan.svg","width":512,"height":389}
fields total:
13
integrity:
16